Search Results - E A Kastelijn

Longitudinal Circulating Tumor DNA–Guided Resistance Analysis During Second-Line Osimertinib Treatment by J.W. Tijmen van der Wel, MD, Merel Jebbink, MD, Vincent van der Noort, PhD, Ferry Lalezari, MD, PhD, Daan van den Broek, PhD, Gerrina Ruiter, MD, PhD, Jacobus A. Burgers, MD, PhD, Paul Baas, MD, PhD, Anne S.R. van Lindert, MD, Eva E. van der Wall, MD, Lisanne E.A. Kastelijn, MD, PhD, Marrit Vermeulen, BSc, Linda J.W. Bosch, PhD, Kim Monkhorst, MD, PhD, Mirjam C. Boelens, PhD, Egbert F. Smit, MD, PhD, Adrianus J. de Langen, MD, PhD

Get full text

Beneficial value of [18F]FDG PET/CT in the follow-up of patients with stage III non-small cell lung cancer (NVALT31-PET study): study protocol of a multicentre randomised controlle... by Wietske Kievit, C Jacobs, S Teerenstra, W Kievit, Steven Teerenstra, M de Vries, Iris Walraven, S R Rutgers, Colin Jacobs, J W G van Putten, Nicole E Billingy, Annemarie Becker-Commissaris, Idris Bahce, M Youssef, Cornelia A Verberkt, Suresh Senan, Marloes J Hassing, Joran Schoorlemmer, Merve Sarioglu, Erik H J G Aarntzen, Emile F I Comans, Astrid Keijser, Michel M van den Heuvel, N C van Walree, C J van Loenhout, Y Berk, R C Boshuizen, K J G Schulkes, M van Laren, M Schiefer, J Dits, E Lammers, E J Geraedts, K W Maas, P Brocken, A C M Mulders, S C van ‘t Westeinde, E Citgez, J N A van Diessen, E A Kastelijn, M A Kroeze, J M W van Haarst, A S R Lindert, I Bahce, S Senan, E F I Comans, N E Billingy, C A Verberkt, M Hassing, J Schoorlemmer, E H J G Aarntzen, M M van den Heuvel, I Walraven, A Becker-Commissaris

Get full text